相关实验视频

Updated: Jun 17, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

针对EphA3的化学抗原受体T细胞在质瘤中有效,并产生治疗性记忆T细胞反应

Leesa Lertsumitkul^1,2, Melinda Iliopoulos¹, Stacie S Wang^1,3

¹Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

Journal for immunotherapy of cancer

|August 7, 2024

概括

化学抗原受体 (CAR) 向以弗林A型受体3 (EphA3) 的T细胞疗法显示出治疗质母细胞瘤 (GBM) 和扩散中线质瘤 (DMG) 等侵袭性脑癌的前景. 临床前研究表明,针对EphA3的CAR T细胞有效地消除瘤并提供长期保护.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
细胞疗法是一种细胞疗法.

背景情况:

高度质瘤 (GBM,DMG) 是致命的脑癌,治疗选择有限.
化学抗原受体 (CAR) T细胞疗法提供了向治疗和血脑屏障的透.
确定最佳瘤抗原对于CAR T细胞治疗的临床成功至关重要.

研究的目的:

确定高度质瘤中CAR T细胞治疗的新细胞表面点.
评估以弗林A型受体3 (EphA3) 向的CAR T细胞对抗GBM和DMG的疗效.

主要方法:

对初级人类质瘤样本的细胞表面蛋白质分析.
第二代EphA3向的CAR T细胞的工程.
在GBM和DMG模型中对CAR T细胞功能的体外和体外评估.

主要成果:

针对EphA3的CAR T细胞在实验室中证明了对GBM和DMG细胞系的特定杀死.
在体内研究表明,在重新挑战时,瘤根除和保护性免疫力.
持续的完整反应观察到与逆侧瘤重新挑战的小鼠.

结论:

在高度质瘤中,EphA3是CAR T细胞治疗的有希望的标.
临床前数据支持EphA3向的CAR T细胞的疗效和临床转化潜力.
这种疗法可以彻底改变对侵袭性脑癌的治疗.

关键词:

化学抗原受体 - - CAR 免疫治疗是一种免疫疗法.

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.